1. Home
  2. SCPH vs PHH Comparison

SCPH vs PHH Comparison

Compare SCPH & PHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • PHH
  • Stock Information
  • Founded
  • SCPH 2013
  • PHH 2016
  • Country
  • SCPH United States
  • PHH China
  • Employees
  • SCPH N/A
  • PHH N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • PHH Package Goods/Cosmetics
  • Sector
  • SCPH Health Care
  • PHH Consumer Discretionary
  • Exchange
  • SCPH Nasdaq
  • PHH Nasdaq
  • Market Cap
  • SCPH 173.6M
  • PHH 160.1M
  • IPO Year
  • SCPH 2017
  • PHH 2024
  • Fundamental
  • Price
  • SCPH $2.57
  • PHH $13.53
  • Analyst Decision
  • SCPH Strong Buy
  • PHH
  • Analyst Count
  • SCPH 3
  • PHH 0
  • Target Price
  • SCPH $14.00
  • PHH N/A
  • AVG Volume (30 Days)
  • SCPH 519.0K
  • PHH 478.5K
  • Earning Date
  • SCPH 05-13-2025
  • PHH 01-01-0001
  • Dividend Yield
  • SCPH N/A
  • PHH N/A
  • EPS Growth
  • SCPH N/A
  • PHH N/A
  • EPS
  • SCPH N/A
  • PHH 0.02
  • Revenue
  • SCPH $36,332,000.00
  • PHH $2,381,851.00
  • Revenue This Year
  • SCPH $114.00
  • PHH N/A
  • Revenue Next Year
  • SCPH $77.45
  • PHH N/A
  • P/E Ratio
  • SCPH N/A
  • PHH $745.66
  • Revenue Growth
  • SCPH 167.28
  • PHH N/A
  • 52 Week Low
  • SCPH $1.94
  • PHH $3.70
  • 52 Week High
  • SCPH $5.65
  • PHH $15.00
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 47.35
  • PHH N/A
  • Support Level
  • SCPH $1.94
  • PHH N/A
  • Resistance Level
  • SCPH $2.71
  • PHH N/A
  • Average True Range (ATR)
  • SCPH 0.27
  • PHH 0.00
  • MACD
  • SCPH 0.04
  • PHH 0.00
  • Stochastic Oscillator
  • SCPH 76.36
  • PHH 0.00

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares

Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries specialize in providing skincare and cosmetic products under its brand name Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.

Share on Social Networks: